These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6956247)

  • 1. Susceptibilities of anaerobic bacteria to N-formimidoyl thienamycin (MK0787) and to other antibiotics.
    Kesado T; Watanabe K; Asahi Y; Isono M; Ueno K
    Antimicrob Agents Chemother; 1982 Jun; 21(6):1016-22. PubMed ID: 6956247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics.
    Kesado T; Hashizume T; Asahi Y
    Antimicrob Agents Chemother; 1980 Jun; 17(6):912-7. PubMed ID: 6931548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-formimidoyl thienamycin (MK0787): in vitro activity against anaerobic bacteria.
    Martin DA; Sanders CV; Marier RL
    Antimicrob Agents Chemother; 1982 Jan; 21(1):168-9. PubMed ID: 6952818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of N-formimidoyl thienamycin (MK0787), a crystalline derivative of thienamycin.
    Horadam VW; Smilack JD; Montgomery CL; Werringloer J
    Antimicrob Agents Chemother; 1980 Oct; 18(4):557-61. PubMed ID: 6934707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.
    Corrado ML; Landesman SH; Cherubin CE
    Antimicrob Agents Chemother; 1980 Dec; 18(6):893-6. PubMed ID: 6263178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria.
    Rolfe RD; Finegold SM
    Antimicrob Agents Chemother; 1981 Nov; 20(5):600-9. PubMed ID: 7325628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of N-formimidoyl thienamycin (MK0787).
    Tally FP; Jacobus NV; Gorbach SL
    Antimicrob Agents Chemother; 1980 Oct; 18(4):642-4. PubMed ID: 6934708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-formimidoyl thienamycin (MK0787): in vitro study.
    Shadomy S; May RS
    Antimicrob Agents Chemother; 1981 Jan; 19(1):201-4. PubMed ID: 6941741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the antibacterial activities of N-formimidoyl thienamycin (MK0787) with those of other recently developed beta-lactam derivatives.
    Cullmann W; Opferkuch W; Stieglitz M; Werkmeister U
    Antimicrob Agents Chemother; 1982 Aug; 22(2):302-7. PubMed ID: 6821459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities.
    Kropp H; Sundelof JG; Kahan JS; Kahan FM; Birnbaum J
    Antimicrob Agents Chemother; 1980 Jun; 17(6):993-1000. PubMed ID: 6931549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin.
    Owens WE; Finegold SM
    Antimicrob Agents Chemother; 1983 Apr; 23(4):626-9. PubMed ID: 6305265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of N-formimidoyl thienamycin and cephalosporins against isolates from nosocomially acquired bacteremia.
    Gutiérrez-Núñez J; Harrington PT; Ramirez-Ronda CH
    Antimicrob Agents Chemother; 1982 Mar; 21(3):509-12. PubMed ID: 6954876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro comparison of N-formimidoyl thienamycin (MK0787) and Azlocillin with three aminoglycosides and ticarcillin against Pseudomonas aeruginosa.
    Matzkowitz AJ; Baltch AL; Smith RP; Sutphen NT; Hammer MC; Conroy JV
    Antimicrob Agents Chemother; 1982 Apr; 21(4):685-7. PubMed ID: 6805426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
    Braveny I; Machka K; Elsser R
    Infection; 1982 Jan; 10(1):45-9. PubMed ID: 6279523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.
    Brown JE; Del Bene VE; Collins CD
    Antimicrob Agents Chemother; 1981 Feb; 19(2):248-52. PubMed ID: 6214986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1982 Jan; 21(1):180-7. PubMed ID: 6979306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime.
    Verbist L; Verhaegen J
    Antimicrob Agents Chemother; 1981 Mar; 19(3):402-6. PubMed ID: 6264844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibacterial activity of N-formimidoyl-thienamycin in comparison with other beta-lactam antibiotics against clinical problem strains (author's transl)].
    Grimm H
    Arzneimittelforschung; 1982; 32(6):595-7. PubMed ID: 6214262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of N-formimidoyl thienamycin (MK0787) against resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, Serratia marcescens, and Enterococcus spp.
    Livingston WK; Elliott AM; Cobbs CG
    Antimicrob Agents Chemother; 1981 Jan; 19(1):114-6. PubMed ID: 6787975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro activity of N-formimidoyl thienamycin compared with other broad-spectrum cephalosporins and with clindamycin and metronidazole.
    Tischhauser G; Kayser FH
    Infection; 1983; 11(4):219-26. PubMed ID: 6578202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.